Skip to main content
Case Study Undergraduate 1,010 words

COVID-19 Case Studies: Diagnosis, Risk Factors, and Treatment

~6 min read 6 sections Health · Diseases
Abstract

This paper presents two clinical case studies examining COVID-19 diagnosis and management. The first case involves a 54-year-old male with recent international travel history, low-grade fever, cough, shortness of breath, and back pain, complicated by hypertension and diabetes mellitus. The second case involves a 68-year-old female with confusion, shortness of breath, and cough but no recent travel history. For each case, the paper discusses diagnostic criteria, CDC testing recommendations, barriers to care posed by comorbidities and age, differential diagnoses, and symptom-focused treatment approaches in the absence of approved antiviral therapy.

Key Takeaways
  • Case Study 1: The 54-Year-Old Male with Travel History: Symptoms, travel history, and COVID-19 testing rationale
  • Comorbidities as Barriers to Treatment: How diabetes and hypertension complicate COVID-19 management
  • Differential Diagnoses for Case Study 1: Rhinovirus and community-acquired pneumonia as alternatives
  • Case Study 2: The 68-Year-Old Female: Elderly patient with respiratory symptoms and no travel history
  • Differential Diagnoses and Management for Case Study 2: RSV and influenza considered alongside COVID-19
  • References: CDC, WHO, and peer-reviewed citation list
✍️ How to write this paper — guide, tools & examples ▾

What makes this paper effective

  • Each case study is methodically structured: it presents patient demographics and symptoms, applies CDC guidance to justify testing, identifies comorbidity-related barriers, and proposes a differential diagnosis — giving the analysis a clear clinical logic.
  • The paper appropriately integrates authoritative sources (CDC, WHO, peer-reviewed journals) to support clinical decisions, strengthening the evidence base for each recommendation.
  • The comparison between two patients of different ages, travel histories, and health backgrounds illustrates how risk stratification changes the clinical approach to COVID-19.

Key academic technique demonstrated

The paper demonstrates applied clinical reasoning by linking each patient's presenting symptoms to diagnostic criteria, then using comorbidity profiles to modify treatment and risk discussions. This symptom-to-decision chain — observation, classification, evidence citation, recommendation — is a core skill in health sciences writing.

Structure breakdown

The paper is divided into two parallel case analyses. Each case covers: (1) patient presentation and travel history, (2) testing rationale based on CDC guidelines, (3) comorbidity or age-related risk factors, (4) treatment planning, and (5) differential diagnoses. A shared reference list closes the paper. The parallel structure makes it easy to compare clinical reasoning across the two scenarios.

Essay 1,010 words

Case Study 1: The 54-Year-Old Male with Travel History

The patient in the first scenario presents with low-grade fever, cough, shortness of breath, and back pain. It is also important to note that the patient suffers from gastroesophageal reflux disease, hypertension, and diabetes mellitus. The patient is a 54-year-old male. Several of the symptoms he presents are consistent with COVID-19, whose core symptoms include difficulty breathing or shortness of breath, cough, and fever (Adhikari, 2020).

Another key consideration in the decision to test is the patient's travel history. The patient has recently traveled outside the United States and could therefore be classified as a person under investigation (PUI) — on the basis of the respiratory illness symptoms presented and the fact that he traveled to a country with local transmission. Testing in this case would be consistent with CDC guidance for COVID-19 with reference to the Recommendations for Reporting, Testing, and Specimen Collection. Towards this end, it is important to note that "for initial diagnostic testing for COVID-19, CDC recommends collecting and testing upper respiratory tract specimens (nasopharyngeal swab)" (CDC, 2020). If the lab results come back positive for the novel virus, the treatment plan would be focused on the alleviation of the symptoms being experienced by the patient, given that at present, COVID-19 has no recommended antiviral medication.

Comorbidities as Barriers to Treatment

There are specific barriers to diagnostic treatment and care in this scenario owing to the patient's comorbidities — namely hypertension and diabetes mellitus. Although the novel virus affects persons irrespective of age, the World Health Organization (WHO, 2020) points out that "people with pre-existing medical conditions (such as asthma, diabetes, heart disease) appear to be more vulnerable to becoming severely ill with the virus." It therefore follows that this 54-year-old is at increased risk of developing severe illness as a consequence of the virus. Treatment would be more difficult because the virus is harder to fight in the context of a compromised immune system. More specifically, with respect to diabetes, elevated blood glucose levels could provide an ideal environment for the virus to thrive.

Taking all of the above factors into consideration, the patient would be advised to maintain adequate fluid intake. The importance of keeping blood glucose levels stable would also be stressed. This could be achieved through adherence to the medication regimen for diabetes and maintaining an appropriate diet — including the consumption of foods with a low glycemic index. Additionally, as Schiffrin, Flack, Sadayoshi, Muntner, and Webb (2020) observe, numerous studies have clearly indicated that proper control of blood pressure is of great relevance in reducing disease burden.

Differential Diagnoses for Case Study 1

The differential diagnoses in the present scenario are rhinovirus infection and community-acquired pneumonia. These diagnoses are made on the basis of the presenting symptoms. Common symptoms of rhinovirus infection include malaise, nasal congestion, cough, sore throat, shortness of breath, and fever. Common symptoms of community-acquired pneumonia include fever and chills, heavy sputum production, coughing, and shortness of breath. Several of the symptoms exhibited by this 54-year-old patient closely mimic those of both rhinovirus infection and community-acquired pneumonia.

Case Study 2: The 68-Year-Old Female

In the second scenario, the patient is a 68-year-old female with no other comorbidities. She presents with slight confusion, shortness of breath (SOB), and cough. It should also be noted that the patient denies having traveled outside the United States over the last six months. On the basis of these facts, her chances of having COVID-19 are comparatively lower, given the absence of recent international travel. Travel to countries with high infection rates increases one's risk of contracting the novel virus (Pung et al., 2020). Nevertheless, on the basis of her presenting symptoms, it would be prudent to take the necessary precautionary measures for her safety and that of those around her.

The first step in this case would be to notify both the local health department and the institution's infection control personnel of this suspected COVID-19 case. The 68-year-old patient is at an especially elevated risk of becoming severely ill due to her age. As WHO (2020) notes, in addition to pre-existing medical conditions, advanced age also appears to be a key contributing factor to severe illness following acquisition of the novel virus. Research has further indicated fewer infections and fatalities among children (Wei, Yuan, and Liu, 2020). To a large extent, the immune system weakens with advancing age, meaning that infections can more readily compromise general health and wellbeing. It would therefore be prudent to ensure that the patient is tested by having a nasal sample taken and dispatched to the laboratory. If COVID-19 results were to come back positive, treatment would commence and would be focused on the alleviation of symptoms. The patient may need to be treated in a hospital setting due to the risk of developing more severe symptoms.

2 Sections Hidden · 180 words
Differential Diagnoses and Management for Case Study 260 words
The two differential diagnoses for the scenario presented would be respiratory syncytial virus and influenza. Some of the shared symptoms in this case include cough, fever,…
References120 words
Adhikari, S.P., Meng, S., Wi, Y., Mao, Y., Ye, R., Wang, Q., … Zhou, H. (2020). Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of…
Key Concepts in This Paper
COVID-19 Diagnosis Person Under Investigation Nasopharyngeal Swab Comorbidities Differential Diagnosis Risk Stratification Community-Acquired Pneumonia Symptom Management Immune Compromise Age-Related Risk
Cite This Paper
PaperDue. (2026). COVID-19 Case Studies: Diagnosis, Risk Factors, and Treatment. PaperDue. https://www.paperdue.com/study-guide/covid-19-case-studies-diagnosis-risk-treatment-2175071

Always verify citation format against your institution’s current style guide requirements.